BridgeBio Pharma, Inc 10-Q for FY2024 Q1
BridgeBio Pharma, Inc. (BBIO)
10-Q
2024-05-02
For: 2024-03-31
View Original
Added on
April 08, 2026
About this 10-Q
BridgeBio Pharma, Inc filed this 10-Q on May 2, 2024, covering the quarter ended March 31, 2024 (FY2024 Q1).
Headline figures
Quarter ended March 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $211.12M
- up 11461.9% from $1.83M a year earlier
- Net loss
- $36.16M
- compared with a net loss of $142.73M a year earlier
- Diluted EPS
- -$0.20
- compared with -$0.92 a year earlier